Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city
Ashtari, Mehdipour, Shaygannejad, Mansourian (2019) Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city Mult Scler Relat Disord (IF: 4) 34 77-82Links
http://www.ncbi.nlm.nih.gov/pubmed/31233958http://dx.doi.org/10.1016/j.msard.2019.06.013
